MICROSATELLITE STABLE COLORECTAL CARCINOMA
Clinical trials for MICROSATELLITE STABLE COLORECTAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new MICROSATELLITE STABLE COLORECTAL CARCINOMA trials appear
Sign up with your email to follow new studies for MICROSATELLITE STABLE COLORECTAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called GI-101, either alone or with pembrolizumab or lenvatinib, in people with advanced solid tumors (cancers that have spread). The goal is to see if it is safe and works against the cancer. About 317 adults with certain cancers like lung, kidney, or…
Matched conditions: MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated May 17, 2026 02:59 UTC
-
New pill hopes to unleash immune system against tough cancers
Disease control Recruiting nowThis early-phase study tests an experimental pill called NX-1607 in adults with advanced cancers that have not responded to standard treatments. The drug aims to boost the body's immune system to fight tumors. The main goals are to check safety and see if the drug can shrink or c…
Matched conditions: MICROSATELLITE STABLE COLORECTAL CARCINOMA
Phase: PHASE1 • Sponsor: Nurix Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC